AbCellera (ABCL) Tops Q2 EPS by 11c

AbCellera (NASDAQ: ABCL) reported Q2 EPS of ($0.02), $0.11 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $12.38 million.

For earnings history and earnings-related data on AbCellera (ABCL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Middleby board approves spin-off of food processing unit Midera
• Jazz Pharmaceuticals and AbCellera ink antibody research deal